{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:08:26Z","timestamp":1766048906418},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Solitary fibrous tumor is a rare type of mesenchymal neoplasm that can be associated to a paraneoplastic severe hypoglycemia due to the overproduction of insulinlike growth factor type 2: Doege-Potter syndrome. When surgical resection is impossible or unsuccessful, alternative therapies were described with heterogeneous efficiency. We report the use of radioembolization with <jats:sup>90<\/jats:sup>Y-labeled glass microspheres in this application. Regarding the excellent results obtained and the potential interest of peptide receptor radionuclide therapy suggested by overexpression of somatostatin receptors in our patient, the place of targeted radionuclide therapies deserves to be explored in this group of tumors.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001944","type":"journal-article","created":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T13:13:28Z","timestamp":1514639608000},"page":"e93-e95","source":"Crossref","is-referenced-by-count":7,"title":["Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome"],"prefix":"10.1097","volume":"43","author":[{"given":"Clement","family":"Bailly","sequence":"first","affiliation":[{"name":"From the *Department of Nuclear Medicine, CHU de Nantes, H\u00f4tel Dieu; \u2020Nantes-Angers Cancer Research Center (CRCNA), University of Nantes, INSERM UMR 1232, Nantes; \u2021Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, H\u00f4pital Nord, Saint-Herblain; and \u00a7Department of Radiology, CHU de Nantes, H\u00f4tel Dieu, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Bichali Alroumani","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, CHU de Nantes, H\u00f4tel Dieu; \u2020Nantes-Angers Cancer Research Center (CRCNA), University of Nantes, INSERM UMR 1232, Nantes; \u2021Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, H\u00f4pital Nord, Saint-Herblain; and \u00a7Department of Radiology, CHU de Nantes, H\u00f4tel Dieu, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Douane","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, CHU de Nantes, H\u00f4tel Dieu; \u2020Nantes-Angers Cancer Research Center (CRCNA), University of Nantes, INSERM UMR 1232, Nantes; \u2021Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, H\u00f4pital Nord, Saint-Herblain; and \u00a7Department of Radiology, CHU de Nantes, H\u00f4tel Dieu, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ansquer","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, CHU de Nantes, H\u00f4tel Dieu; \u2020Nantes-Angers Cancer Research Center (CRCNA), University of Nantes, INSERM UMR 1232, Nantes; \u2021Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, H\u00f4pital Nord, Saint-Herblain; and \u00a7Department of Radiology, CHU de Nantes, H\u00f4tel Dieu, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, CHU de Nantes, H\u00f4tel Dieu; \u2020Nantes-Angers Cancer Research Center (CRCNA), University of Nantes, INSERM UMR 1232, Nantes; \u2021Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, H\u00f4pital Nord, Saint-Herblain; and \u00a7Department of Radiology, CHU de Nantes, H\u00f4tel Dieu, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":":e7417","DOI":"10.1097\/MD.0000000000007417","article-title":"Doege-Potter syndrome: a review of the literature including a new case report","volume":"96","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/1756-0500-7-515","article-title":"Solitary fibrous tumors of the pleura with Doege-Potter syndrome: a case report and three-decade review of the literature","volume":"7","year":"2014","journal-title":"BMC Res Notes"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/1097-0142(19810601)47:11<2678::AID-CNCR2820471126>3.0.CO;2-9","article-title":"Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature","volume":"47","year":"1981","journal-title":"Cancer"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00776-013-0462-6","article-title":"Solitary fibrous tumor in the pelvis: induced hypoglycemia associated with insulin-like growth factor II","volume":"20","year":"2015","journal-title":"J Orthop Sci"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-3329-3-7","article-title":"The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis","volume":"3","year":"2013","journal-title":"Clin Sarcoma Res"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cncr.28506","article-title":"Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors","volume":"120","year":"2014","journal-title":"Cancer"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1097\/RLU.0000000000001648","article-title":"68Ga-DOTATOC PET\/CT imaging in solitary fibrous tumor of the pleura","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2011-1563","article-title":"Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201803000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:08:49Z","timestamp":1697861329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201803000-00030"}},"subtitle":["Hypoglycemia Treated by 90Y Radioembolization"],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001944","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}